FINANCIAL HIGHLIGHTS (QQ1 2026) — ADVB reported no disclosed revenue in QQ1 2026; operating expenses were $523,914, comprising $235,992 in R&D and $260,603 in G&A (selling and SG&A combined with G&A equals $260,603). Depreciation and amortization were $47,992. EBITDA stood at $-475,922 and operating income was $-523,914. Total other income/expenses net contributed $137,013, resulting in income before tax of $-386,901 and net income of $-386,901. EPS: $-0.02, weighted average shares outstanding: 21.64 million.
CASH FLOW AND LIQUIDITY — Cash from operating activities was negative $20,390 for QQ1 2026. Net cash used in investing activities was $-59 (PPE), with debt repayments of $14,949 contributing to financing activity cash inflows of $14,949. The effect of foreign exchange reduced cash by $-6,746. Net change in cash was $-12,247, leaving a cash balance of $87,161 at period end. Balance sheet shows cash and cash equivalents of $2,656,519 and total debt of $1,701,878 (short-term $1,507,984; long-term $2,935). Net debt stood at $-2,625,650, driven by a strong cash position relative to modest reported debt.
BALANCE SHEET AND PROFITABILITY PROFILE — Total assets: $6,242,970; total liabilities: $3,238,846; total stockholders’ equity: $3,004,124. Retained earnings sit at $(19,619,945), indicating accumulated losses on the balance sheet despite a positive equity base supported by accumulated other comprehensive income of $1,255,151 and other stockholders’ equity of $21,347,278. Current ratio is reported at 1.92x, with a debt-to-equity ratio of 0.019x and a debt ratio of 0.009x, signaling a conservative leverage profile.
YoY and QoQ context (where available) show improving operating income and net income metrics in the period-to-period comparison, yet remain negative in QQ1 2026: operating income YoY is +30.85% and net income YoY is +58.52%, with EPS YoY +57.08%. These changes reflect a narrowing loss trajectory rather than profitability at this stage.